Boston doctor calls new pancreatic cancer drug "exceptional moment"
When the news broke that the Food and Drug Administration approved a new drug for pancreatic cancer patients, it gave patients fighting the disease a glimmer of long-awaited hope.
Watch CBS News
When the news broke that the Food and Drug Administration approved a new drug for pancreatic cancer patients, it gave patients fighting the disease a glimmer of long-awaited hope.
A new drug for some patients with pancreatic cancer has been approved by the FDA.
The FDA has approved a new targeted drug for advanced pancreatic cancer, offering a new treatment option for those with limited choices.
In trials, a vaccine for pancreatic cancer developed by Sloan-Ketterin and BioNTech showed promise, but researchers say it is still too early to tell.
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.
Two studies have found that Ozempic does not put people at a higher risk of some side effects.
With a broken yet resilient heart, Tim Duffy is determined to make an impact.
With a broken yet resilient heart, Tim Duffy is determined to make an impact. WBZ-TV's Paul Burton reports.
